|
Volumn 24, Issue 6, 1997, Pages 691-697
|
A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer
a a a a a a a a a a a a |
Author keywords
CDDP; Droperidol; Emesis; Granisetron; Methylprednisolone
|
Indexed keywords
ACLACINOMYCIN;
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
DROPERIDOL;
ETOPOSIDE;
GRANISETRON;
IFOSFAMIDE;
METHYLPREDNISOLONE;
MITOMYCIN C;
PEPLEOMYCIN;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG RESPONSE;
FEMALE;
GYNECOLOGIC CANCER;
HUMAN;
RANDOMIZED CONTROLLED TRIAL;
VOMITING;
ADOLESCENT;
ADULT;
AGED;
ANTIEMETICS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
CROSS-OVER STUDIES;
DROPERIDOL;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
GENITAL NEOPLASMS, FEMALE;
GRANISETRON;
HUMANS;
METHYLPREDNISOLONE;
MIDDLE AGED;
NAUSEA;
OVARIAN NEOPLASMS;
UTERINE NEOPLASMS;
VOMITING;
|
EID: 0030883962
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (12)
|